PRF Technologies Ltd. filings document a foreign private issuer with healthcare and solar analytics operations. Current reports on Form 6-K disclose regulatory and development updates for OcuRing™-K, LayerBio’s sustained-release ocular drug-delivery platform, as well as DeepSolar commercial agreements, SaaS deployments, technical due diligence services, patent-related activity, and business updates tied to the company’s operating platforms.
The filing record also covers capital structure and governance matters, including ordinary-share financing arrangements, registration statement incorporation for Form F-3 and Form S-8 purposes, board and executive changes, committee independence, and share-capital actions. PRF’s annual reporting on Form 20-F provides the broader framework for its business, risk factors, operating results, subsidiaries, and public-company controls.
PRF Technologies Ltd. (PRFX) received a September 24, 2026 letter from S.H.N. Financial Investments Ltd., which purports to hold approximately 5.7% of the company’s voting rights. S.H.N. requested a special general meeting to remove the directors other than the external directors and appoint three S.H.N. nominees. The company is reviewing the letter and considering its next steps.
PRF Technologies Ltd. received a demand from shareholder S.H.N. Financial Investments Ltd. to convene a special general meeting. S.H.N. reported sole voting and dispositive power over 200,000 ordinary shares, representing 5.716% of the company’s share capital; the reported percentage is based on 3,499,144 ordinary shares outstanding as of September 2, 2026.
S.H.N. requested that the meeting agenda include proposals to remove current directors other than Dr. Ellen S. Baron and Augustine Lawlor, and to elect S.H.N.’s nominees. S.H.N. said it intends to discuss the proposals with the company’s board, management, shareholders and other interested parties, and may seek shareholder support.
PRF Technologies Ltd. (PRFX) reported that GridFeed™, its AI-driven energy intelligence platform, is exploring the AI and hyperscale data center market as a strategic growth opportunity. Management believes GridFeed’s existing “predict, simulate, optimize and recommend” engine, currently used for renewable assets and batteries, could help data centers manage limited power capacity and allocate each megawatt to its highest-value use.
The company plans to evaluate applications such as workload shifting, energy cost optimization, battery charge/discharge strategies, demand response and real-time power allocation with industry partners across the data center ecosystem. PRF recently decided to establish GridFeed, together with DeepSolar operations, as a standalone, wholly owned subsidiary to provide flexibility to pursue new markets, including data centers, while continuing its pharmaceutical reformulation programs.
PRF Technologies Ltd. (PRFX) plans to establish its AI-based renewable energy trading platform GridFeed™, together with DeepSolar operations, as a standalone wholly owned subsidiary to create a dedicated vehicle for growth and commercialization. The structure is intended to let GridFeed pursue direct strategic investments, partnerships and commercial collaborations with energy-market participants and sector-focused investors.
GridFeed’s platform uses DeepSolar’s AI engine to combine localized weather intelligence, production forecasting, battery storage orchestration and market analytics to support trading decisions and reduce imbalance exposure for solar, wind and battery assets. GridFeed will be showcased to more than 2,500 professionals at Energy Trading Week Europe 2026 in London. PRF reports ending the second quarter of 2026 with $11.6 million in cash and continues to advance its healthcare pipeline, including a planned U.S. multi-center Phase II trial of OcuRing™-K.
PRF Technologies Ltd. (PRFX) filed a post-effective amendment to its Form F-1 to update financial and other information for an existing resale registration tied to a Standby Equity Purchase Agreement with YA II PN, LTD. The amendment continues to register up to 7,042,724 ordinary shares for resale by YA as potential “Advance Shares” that PRF may sell to YA under the agreement. PRF is not selling securities directly in this offering and will not receive proceeds from YA’s resales, though it may raise up to $15.0 million in aggregate from primary sales of ordinary shares to YA at 97% of the lowest three-day VWAP during each pricing period. As of September 2, 2026, PRF had 3,499,144 ordinary shares outstanding, and full use of the equity line as registered would increase this to 10,541,868 shares, highlighting significant potential dilution and resale overhang. The filing also describes prior completion of a separate $10.0 million equity facility with YA, a recent 1‑for‑5 reverse share split, the company’s dual focus on specialty pharmaceuticals and AI-driven solar analytics, and risks related to Nasdaq continued listing, including a proposed Market Value of Listed Securities requirement.
PRF Technologies Ltd. (PRFX) reported first-half 2026 results showing a larger loss but a much stronger balance sheet, alongside progress in both its healthcare and AI energy businesses. Revenue reached $14 thousand, while comprehensive loss attributable to shareholders was $2.8 million versus $2.3 million a year earlier, driven by higher R&D and equity-line financing costs.
Cash, short-term deposits and restricted cash rose to about $11.6 million with positive working capital of $9.5 million, supported by a $10.0 million SEPA raise and access to a further $15.0 million facility. The FDA cleared the IND for OcuRing™-K enabling a U.S. Phase II cataract trial, PRF-110 showed 72-hour analgesic activity comparable to an approved extended-release pain product in preclinical testing, and DeepSolar began generating revenue and added new AI-based offerings. The company remains loss-making and highlights Nasdaq listing risk tied to a proposed $5.0 million Market Value of Listed Securities requirement, while relying on additional equity financing and issuing shares that increased its outstanding count to 3,041,830 as of June 30, 2026.
PRF Technologies Ltd. reports that on May 28, 2026 it raised $10 million through an equity line facility, which it states substantially strengthened its balance sheet and increased strategic flexibility to accelerate existing businesses and pursue additional growth opportunities across its biotechnology and AI-driven energy platforms.
The majority-owned biotech subsidiary LayerBio is preparing to commence a planned Phase 2 clinical trial of OcuRing™-K, a sustained-release anti-inflammatory implant placed on the intraocular lens during cataract surgery, while lead candidate PRF-110 showed sustained 72-hour analgesic activity in a head-to-head preclinical study. The DeepSolar and GridFeed energy technologies advanced through validation with real-world European market data, addition of Battery-to-Revenue Intelligence for storage assets, participation in the NVIDIA Connect program and a planned GridFeed showcase at Energy Trading Week Europe 2026.
PRF Technologies Ltd. (Nasdaq: PRFX) reported that its DeepSolar business unit will participate in Energy Trading Week Europe 2026 in London on September 24–25, 2026. The company plans to showcase GridFeed™, an AI-driven platform for renewable energy trading, market participation and revenue optimization built on its DeepSolar Predict AI engine.
PRF intends to present GridFeed to energy traders, asset owners, operators and other market participants, join an industry panel and hold meetings with prospective customers and partners. Management describes this participation as an important step in its go-to-market strategy as GridFeed evolves from forecasting and analytics toward trading decision support and revenue-focused workflows.
PRF Technologies Ltd. reported that it has expanded its AI-driven renewable energy revenue optimization platform, DeepSolar Predict™, with a new Battery-to-Revenue Intelligence capability. This feature is designed to extend optimization workflows from solar generation to battery energy storage assets, helping operators decide when to store, dispatch or preserve capacity based on market conditions, production forecasts and grid dynamics. The expansion follows recently completed real-world validation of DeepSolar Predict using European market data as the solution advances toward a planned commercial launch.
PRF plans additional tools such as a “What-if Battery Scenario” module to assess potential revenue impacts of adding or operating storage within renewable portfolios, and expects these capabilities to underpin GridFeed™, a planned trading and market-participation platform. The company also reiterates extensive forward-looking risks, including going concern uncertainty, a history of losses, dependence on key product candidates and energy software commercialization, capital-raising needs, regulatory challenges and exposure to political and security conditions in Israel.